{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T12:17:38Z","timestamp":1784204258414,"version":"3.55.0"},"reference-count":157,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T00:00:00Z","timestamp":1736553600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T00:00:00Z","timestamp":1736553600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Radiol"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Adrenal diseases pose significant diagnostic challenges due to the wide range of neoplastic and non-neoplastic pathologies. Radiologists have a crucial role in diagnosing and managing these conditions by, leveraging advanced imaging techniques. This review discusses the vital role of computed tomography (CT), magnetic resonance imaging (MRI), and nuclear medicine in adrenal imaging, and focuses on morphological and functional evaluations. First, the anatomy and physiology of the adrenal glands are described, followed by a discussion on ectopic adrenocortical adenomas and how they develop. The concepts and imaging findings of congenital diseases, such as congenital adrenal hyperplasia (CAH), adrenal rest tumors, and adrenocortical nodular disease, considering recent updates to the WHO Classification of Tumours (5th ed.) terminology are highlighted. The diagnostic value of dynamic contrast-enhanced CT and chemical-shift MRI for identifying adrenocortical adenomas are emphasized, alongside the use of adrenocortical scintigraphy such as <jats:sup>131<\/jats:sup>I-adosterol scintigraphy for diagnosing Cushing\u2019s disease, Cushing\u2019s syndrome (CS), subclinical CS, and ectopic adrenocorticotropic hormone-producing tumors. Systemic complications associated with CS, and the diagnosis and treatment of pheochromocytomas, paragangliomas (PPGLs), and neuroblastomas, will also be discussed focusing on <jats:sup>123<\/jats:sup>I-metaiodobenzylguanidine (MIBG) imaging and <jats:sup>131<\/jats:sup>I-MIBG therapy. Pitfalls in <jats:sup>123<\/jats:sup>I-MIBG imaging and the increasing importance of diagnosing hereditary PPGLs due to increased genetic testing are also be discussed. Additionally, the broad differential diagnosis for adrenal masses\u2014including malignancies like adrenal carcinoma, metastases, and malignant lymphoma, as well as benign conditions like myelolipoma and ganglioneuroma, and complications, such as adrenal hemorrhage, infarction, and infections\u2014will be outlined. The goal of this review was to provide an overview of adrenal diseases that includes the most recent information for radiologists to stay updated on the latest imaging techniques and advancements that can ensure accurate diagnosis and effective management.<\/jats:p>","DOI":"10.1007\/s11604-025-01732-6","type":"journal-article","created":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T02:35:55Z","timestamp":1736562955000},"page":"903-926","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Advances in multimodal imaging for adrenal gland disorders: integrating CT, MRI, and nuclear medicine"],"prefix":"10.1007","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5151-3146","authenticated-orcid":false,"given":"Kota","family":"Yokoyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Matsuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Isozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0905-6767","authenticated-orcid":false,"given":"Kimiteru","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3031-2737","authenticated-orcid":false,"given":"Tomoki","family":"Imokawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akane","family":"Ozawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3190-8508","authenticated-orcid":false,"given":"Koichiro","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8392-2227","authenticated-orcid":false,"given":"Junichi","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ukihide","family":"Tateishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,11]]},"reference":[{"key":"1732_CR1","volume-title":"Endocrine and neuroendocrine tumors","author":"A Lori","year":"2022","unstructured":"Lori A, Erickson AJG, de Krijger RR, Papotti M. Endocrine and neuroendocrine tumors. 5th ed. Lyon (France): International Agency for Research on Cancer; 2022.","edition":"5"},{"key":"1732_CR2","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1148\/radiol.2021210231","volume":"301","author":"Y Nagayama","year":"2021","unstructured":"Nagayama Y, Inoue T, Kato Y, Tanoue S, Kidoh M, Oda S, et al. Relative enhancement ratio of portal venous phase to unenhanced CT in the diagnosis of lipid-poor adrenal adenomas. Radiology. 2021;301:360\u20138.","journal-title":"Radiology"},{"key":"1732_CR3","doi-asserted-by":"publisher","first-page":"747","DOI":"10.2214\/ajr.170.3.9490968","volume":"170","author":"M Korobkin","year":"1998","unstructured":"Korobkin M, Brodeur FJ, Francis IR, Quint LE, Dunnick NR, Londy F. CT time-attenuation washout curves of adrenal adenomas and nonadenomas. AJR Am J Roentgenol. 1998;170:747\u201352.","journal-title":"AJR Am J Roentgenol"},{"key":"1732_CR4","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1148\/radiology.200.3.8756925","volume":"200","author":"M Korobkin","year":"1996","unstructured":"Korobkin M, Giordano TJ, Brodeur FJ, Francis IR, Siegelman ES, Quint LE, et al. Adrenal adenomas: relationship between histologic lipid and CT and MR findings. Radiology. 1996;200:743\u20137.","journal-title":"Radiology"},{"key":"1732_CR5","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1007\/s00330-018-5626-5","volume":"29","author":"I Platzek","year":"2019","unstructured":"Platzek I, Sieron D, Plodeck V, Borkowetz A, Laniado M, Hoffmann RT. Chemical shift imaging for evaluation of adrenal masses: a systematic review and meta-analysis. Eur Radiol. 2019;29:806\u201317.","journal-title":"Eur Radiol"},{"key":"1732_CR6","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1055\/s-0031-1299712","volume":"44","author":"HJ Timmers","year":"2012","unstructured":"Timmers HJ, Taieb D, Pacak K. Current and future anatomical and functional imaging approaches to pheochromocytoma and paraganglioma. Horm Metab Res. 2012;44:367\u201372.","journal-title":"Horm Metab Res"},{"key":"1732_CR7","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/j.1365-2265.2008.03256.x","volume":"69","author":"KS Bhatia","year":"2008","unstructured":"Bhatia KS, Ismail MM, Sahdev A, Rockall AG, Hogarth K, Canizales A, et al. 123I-metaiodobenzylguanidine (MIBG) scintigraphy for the detection of adrenal and extra-adrenal phaeochromocytomas: CT and MRI correlation. Clin Endocrinol (Oxf). 2008;69:181\u20138.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1732_CR8","doi-asserted-by":"publisher","first-page":"4757","DOI":"10.1210\/jc.2009-1248","volume":"94","author":"HJ Timmers","year":"2009","unstructured":"Timmers HJ, Chen CC, Carrasquillo JA, Whatley M, Ling A, Havekes B, et al. Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma. J Clin Endocrinol Metab. 2009;94:4757\u201367.","journal-title":"J Clin Endocrinol Metab"},{"key":"1732_CR9","doi-asserted-by":"publisher","first-page":"1784","DOI":"10.1007\/s00259-016-3357-x","volume":"43","author":"I Janssen","year":"2016","unstructured":"Janssen I, Chen CC, Millo CM, Ling A, Taieb D, Lin FI, et al. PET\/CT comparing (68)Ga-DOTATATE and other radiopharmaceuticals and in comparison with CT\/MRI for the localization of sporadic metastatic pheochromocytoma and paraganglioma. Eur J Nucl Med Mol Imaging. 2016;43:1784\u201391.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1732_CR10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10354-018-0658-7","volume":"169","author":"AS Kroiss","year":"2019","unstructured":"Kroiss AS. Current status of functional imaging in neuroblastoma, pheochromocytoma, and paraganglioma disease. Wien Med Wochenschr. 2019;169:25\u201332.","journal-title":"Wien Med Wochenschr"},{"key":"1732_CR11","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.3390\/cancers11101505","volume":"11","author":"S N\u00f6lting","year":"2019","unstructured":"N\u00f6lting S, Ullrich M, Pietzsch J, Ziegler CG, Eisenhofer G, Grossman A, et al. Current management of pheochromocytoma\/paraganglioma: a guide for the practicing clinician in the era of precision medicine. Cancers (Basel). 2019;11:1505.","journal-title":"Cancers (Basel)"},{"key":"1732_CR12","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.surg.2017.05.025","volume":"163","author":"P Nockel","year":"2018","unstructured":"Nockel P, El Lakis M, Gaitanidis A, Yang L, Merkel R, Patel D, et al. Preoperative genetic testing in pheochromocytomas and paragangliomas influences the surgical approach and the extent of adrenal surgery. Surgery. 2018;163:191\u20136.","journal-title":"Surgery"},{"key":"1732_CR13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1530\/ERC-13-0415","volume":"21","author":"B Bausch","year":"2014","unstructured":"Bausch B, Wellner U, Bausch D, Schiavi F, Barontini M, Sanso G, et al. Long-term prognosis of patients with pediatric pheochromocytoma. Endocr Relat Cancer. 2014;21:17\u201325.","journal-title":"Endocr Relat Cancer"},{"key":"1732_CR14","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1148\/rg.220108","volume":"42","author":"GS Shroff","year":"2022","unstructured":"Shroff GS, Strange CD, Ahuja J, Altan M, Sheshadri A, Unlu E, et al. Imaging of immune checkpoint inhibitor immunotherapy for non-small cell lung cancer. Radiographics. 2022;42:1956\u201374.","journal-title":"Radiographics"},{"key":"1732_CR15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1385\/EP:12:1:33","volume":"12","author":"KY Lam","year":"2001","unstructured":"Lam KY, Chan AC, Lo CY. Morphological analysis of adrenal glands: a prospective analysis. Endocr Pathol. 2001;12:33\u20138.","journal-title":"Endocr Pathol"},{"key":"1732_CR16","first-page":"333","volume":"55","author":"E Gurun","year":"2021","unstructured":"Gurun E, Kaya M, Gurun KH. Evaluation of normal adrenal gland volume and morphometry and relationship with waist circumference in an adult population using multidetector computed tomography. Sisli Etfal Hastan Tip Bul. 2021;55:333\u20138.","journal-title":"Sisli Etfal Hastan Tip Bul"},{"key":"1732_CR17","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S0009-9260(05)81739-8","volume":"49","author":"JM Vincent","year":"1994","unstructured":"Vincent JM, Morrison ID, Armstrong P, Reznek RH. The size of normal adrenal glands on computed tomography. Clin Radiol. 1994;49:453\u20135.","journal-title":"Clin Radiol"},{"key":"1732_CR18","volume-title":"Anatomy for diagnostic imaging","author":"S Ryan","year":"2011","unstructured":"Ryan S, McNicholas M, Eustace SJ. Anatomy for diagnostic imaging. Saunders\/Elsevier; 2011."},{"key":"1732_CR19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1002\/jcu.1870140109","volume":"14","author":"H Kangarloo","year":"1986","unstructured":"Kangarloo H, Diament MJ, Gold RH, Barrett C, Lippe B, Geffner M, et al. Sonography of adrenal glands in neonates and children: changes in appearance with age. J Clin Ultrasound. 1986;14:43\u20137.","journal-title":"J Clin Ultrasound"},{"key":"1732_CR20","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1002\/uog.11169","volume":"40","author":"SH van Vuuren","year":"2012","unstructured":"van Vuuren SH, Damen-Elias HA, Stigter RH, van der Doef R, Goldschmeding R, de Jong TP, et al. Size and volume charts of fetal kidney, renal pelvis and adrenal gland. Ultrasound Obstet Gynecol. 2012;40:659\u201364.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"1732_CR21","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1080\/14767058.2017.1378340","volume":"32","author":"T Karsli","year":"2019","unstructured":"Karsli T, Strickland D, Livingston J, Wu Q, Mhanna MJ, Shekhawat PS. Assessment of neonatal adrenal size using high resolution 2D ultrasound and its correlation with birth demographics and clinical outcomes. J Matern Fetal Neonatal Med. 2019;32:377\u201383.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"1732_CR22","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1007\/s00261-014-0287-6","volume":"40","author":"VB Planz","year":"2015","unstructured":"Planz VB, Dyer RB. The \u201cpancake\u201d adrenal. Abdom Imaging. 2015;40:2041\u20133.","journal-title":"Abdom Imaging"},{"key":"1732_CR23","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1007\/s00261-016-0889-2","volume":"42","author":"LJ Minshew","year":"2017","unstructured":"Minshew LJ, Williams HJ, DiSantis DJ. The \u201cbutterfly\u201d adrenal gland. Abdom Radiol (NY). 2017;42:661\u20132.","journal-title":"Abdom Radiol (NY)"},{"key":"1732_CR24","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1148\/rg.2017170043","volume":"37","author":"KM Sargar","year":"2017","unstructured":"Sargar KM, Khanna G, Hulett BR. Imaging of nonmalignant adrenal lesions in children. Radiographics. 2017;37:1648\u201364.","journal-title":"Radiographics"},{"key":"1732_CR25","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.crad.2005.04.006","volume":"60","author":"TD Barwick","year":"2005","unstructured":"Barwick TD, Malhotra A, Webb JA, Savage MO, Reznek RH. Embryology of the adrenal glands and its relevance to diagnostic imaging. Clin Radiol. 2005;60:953\u20139.","journal-title":"Clin Radiol"},{"key":"1732_CR26","doi-asserted-by":"publisher","first-page":"e205","DOI":"10.1259\/bjr\/52038548","volume":"80","author":"F Ors","year":"2007","unstructured":"Ors F, Lev-Toaff A, O\u2019Kane P, Qazi N, Bergin D. Paraovarian adrenal rest with MRI features characteristic of an adrenal adenoma. Br J Radiol. 2007;80:e205\u20138.","journal-title":"Br J Radiol"},{"key":"1732_CR27","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1056\/NEJMra1807486","volume":"381","author":"RL Rushworth","year":"2019","unstructured":"Rushworth RL, Torpy DJ, Falhammar H. Adrenal Crisis. N Engl J Med. 2019;381:852\u201361.","journal-title":"N Engl J Med"},{"key":"1732_CR28","unstructured":"Yau M, Khattab A, Yuen T, New M. Congenital Adrenal Hyperplasia. In: Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, et al., editors. Endotext. South Dartmouth (MA): MDText.com, Inc. Copyright \u00a9 2000-2024, MDText.com, Inc.; 2000"},{"key":"1732_CR29","first-page":"Cd012517","volume":"3","author":"SM Ng","year":"2020","unstructured":"Ng SM, Stepien KM, Krishan A. Glucocorticoid replacement regimens for treating congenital adrenal hyperplasia. Cochrane Database Syst Rev. 2020;3:Cd012517.","journal-title":"Cochrane Database Syst Rev"},{"key":"1732_CR30","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1177\/1742271X20951915","volume":"29","author":"TS Aderotimi","year":"2021","unstructured":"Aderotimi TS, Kraft JK. Ultrasound of the adrenal gland in children. Ultrasound. 2021;29:48\u201356.","journal-title":"Ultrasound"},{"key":"1732_CR31","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/s00247-001-0592-4","volume":"32","author":"M Hernanz-Schulman","year":"2002","unstructured":"Hernanz-Schulman M, Brock JW 3rd, Russell W. Sonographic findings in infants with congenital adrenal hyperplasia. Pediatr Radiol. 2002;32:130\u20137.","journal-title":"Pediatr Radiol"},{"key":"1732_CR32","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/S0022-3476(99)70330-6","volume":"135","author":"I Al-Alwan","year":"1999","unstructured":"Al-Alwan I, Navarro O, Daneman D, Daneman A. Clinical utility of adrenal ultrasonography in the diagnosis of congenital adrenal hyperplasia. J Pediatr. 1999;135:71\u20135.","journal-title":"J Pediatr"},{"key":"1732_CR33","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0720-048X(01)00442-9","volume":"41","author":"A Kurtaran","year":"2002","unstructured":"Kurtaran A, Traub T, Shapiro B. Scintigraphic imaging of the adrenal glands. Eur J Radiol. 2002;41:123\u201330.","journal-title":"Eur J Radiol"},{"key":"1732_CR34","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1177\/2051415818755627","volume":"13","author":"LE Hempenstall","year":"2018","unstructured":"Hempenstall LE, Kwok M, Siriwardana AR, Wang G, Desai D, Gleeson J. Testicular masses in congenital adrenal hyperplasia: using 123I-MIBG scintigraphy to support the diagnosis of testicular adrenal rest tumors. J Clin Urol. 2018;13:122\u20134.","journal-title":"J Clin Urol"},{"key":"1732_CR35","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.jpurol.2023.10.005","volume":"20","author":"JL de Eyer","year":"2024","unstructured":"de Eyer JL, de Paz Oliveira AP, Porto LC, Dekermacher S. Testicular adrenal rest tumors\u2014epidemiology, diagnosis and treatment. J Pediatr Urol. 2024;20:77\u201387.","journal-title":"J Pediatr Urol"},{"key":"1732_CR36","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/S0140-6736(22)01330-7","volume":"401","author":"MK Auer","year":"2023","unstructured":"Auer MK, Nordenstr\u00f6m A, Lajic S, Reisch N. Congenital adrenal hyperplasia. Lancet. 2023;401:227\u201344.","journal-title":"Lancet"},{"key":"1732_CR37","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s11604-023-01412-3","volume":"41","author":"Y Fushimi","year":"2023","unstructured":"Fushimi Y, Taoka T, Naganawa S. From pituitary adenoma to PitNET: it is time to discuss PitNET\/pituitary adenoma. Jpn J Radiol. 2023;41:787\u20138.","journal-title":"Jpn J Radiol"},{"key":"1732_CR38","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/978-3-319-29043-0_15","volume-title":"MRI of the pituitary gland","author":"J-F Bonneville","year":"2016","unstructured":"Bonneville J-F. Cushing disease. In: Bonneville J-F, Bonneville F, Cattin F, Nagi S, editors. MRI of the pituitary gland. Cham: Springer International Publishing; 2016. p. 107\u201311."},{"key":"1732_CR39","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1148\/radiology.177.1.2399335","volume":"177","author":"Y Miki","year":"1990","unstructured":"Miki Y, Matsuo M, Nishizawa S, Kuroda Y, Keyaki A, Makita Y, et al. Pituitary adenomas and normal pituitary tissue: enhancement patterns on gadopentetate-enhanced MR imaging. Radiology. 1990;177:35\u20138.","journal-title":"Radiology"},{"key":"1732_CR40","doi-asserted-by":"publisher","first-page":"S208","DOI":"10.21037\/gs.2019.06.08","volume":"8","author":"M Varrassi","year":"2019","unstructured":"Varrassi M, Cobianchi Bellisari F, Bruno F, Palumbo P, Natella R, Maggialetti N, et al. High-resolution magnetic resonance imaging at 3T of pituitary gland: advantages and pitfalls. Gland Surg. 2019;8:S208\u201315.","journal-title":"Gland Surg"},{"key":"1732_CR41","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1007\/s11604-023-01407-0","volume":"41","author":"T Tsukamoto","year":"2023","unstructured":"Tsukamoto T, Miki Y. Imaging of pituitary tumors: an update with the 5th WHO Classifications-part 2. Neoplasms other than PitNET and tumor-mimicking lesions. Jpn J Radiol. 2023;41:808\u201329.","journal-title":"Jpn J Radiol"},{"key":"1732_CR42","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1007\/s11604-012-0168-2","volume":"31","author":"A Yamamoto","year":"2013","unstructured":"Yamamoto A, Oba H, Furui S. Influence of age and sex on signal intensities of the posterior lobe of the pituitary gland on T1-weighted images from 3 T MRI. Jpn J Radiol. 2013;31:186\u201391.","journal-title":"Jpn J Radiol"},{"key":"1732_CR43","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1007\/s12020-018-1779-x","volume":"63","author":"S Chen","year":"2019","unstructured":"Chen S, Chen K, Lu L, Zhang X, Tong A, Pan H, et al. The effects of sampling lateralization on bilateral inferior petrosal sinus sampling and desmopressin stimulation test for pediatric Cushing\u2019s disease. Endocrine. 2019;63:582\u201391.","journal-title":"Endocrine"},{"key":"1732_CR44","first-page":"690","volume":"21","author":"FS Bonelli","year":"2000","unstructured":"Bonelli FS, Huston J 3rd, Carpenter PC, Erickson D, Young WF Jr, Meyer FB. Adrenocorticotropic hormone-dependent Cushing\u2019s syndrome: sensitivity and specificity of inferior petrosal sinus sampling. AJNR Am J Neuroradiol. 2000;21:690\u20136.","journal-title":"AJNR Am J Neuroradiol"},{"key":"1732_CR45","doi-asserted-by":"publisher","first-page":"R12","DOI":"10.1530\/EC-16-0029","volume":"5","author":"B Zampetti","year":"2016","unstructured":"Zampetti B, Grossrubatscher E, Dalino Ciaramella P, Boccardi E, Loli P. Bilateral inferior petrosal sinus sampling. Endocr Connect. 2016;5:R12-25.","journal-title":"Endocr Connect"},{"key":"1732_CR46","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/nrendo.2011.12","volume":"7","author":"NA Tritos","year":"2011","unstructured":"Tritos NA, Biller BM, Swearingen B. Management of cushing disease. Nat Rev Endocrinol. 2011;7:279\u201389.","journal-title":"Nat Rev Endocrinol"},{"key":"1732_CR47","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.4158\/EP13171.OR","volume":"19","author":"HR Kakade","year":"2013","unstructured":"Kakade HR, Kasaliwal R, Jagtap VS, Bukan A, Budyal SR, Khare S, et al. Ectopic ACTH-secreting syndrome: a single-center experience. Endocr Pract. 2013;19:1007\u201314.","journal-title":"Endocr Pract"},{"key":"1732_CR48","doi-asserted-by":"publisher","first-page":"4955","DOI":"10.1210\/jc.2004-2527","volume":"90","author":"I Ilias","year":"2005","unstructured":"Ilias I, Torpy DJ, Pacak K, Mullen N, Wesley RA, Nieman LK. Cushing\u2019s syndrome due to ectopic corticotropin secretion: twenty years\u2019 experience at the National Institutes of Health. J Clin Endocrinol Metab. 2005;90:4955\u201362.","journal-title":"J Clin Endocrinol Metab"},{"key":"1732_CR49","doi-asserted-by":"publisher","first-page":"e0242679","DOI":"10.1371\/journal.pone.0242679","volume":"15","author":"JE Pale\u0144-Tytko","year":"2020","unstructured":"Pale\u0144-Tytko JE, Przybylik-Mazurek EM, Rzepka EJ, Pach DM, Sowa-Staszczak AS, Gilis-Januszewska A, et al. Ectopic ACTH syndrome of different origin-Diagnostic approach and clinical outcome. Experience of one Clinical Centre. PLoS ONE. 2020;15:e0242679.","journal-title":"PLoS ONE"},{"key":"1732_CR50","doi-asserted-by":"publisher","first-page":"19","DOI":"10.2214\/AJR.16.17290","volume":"209","author":"NA Wagner-Bartak","year":"2017","unstructured":"Wagner-Bartak NA, Baiomy A, Habra MA, Mukhi SV, Morani AC, Korivi BR, et al. Cushing syndrome: diagnostic workup and imaging features, with clinical and pathologic correlation. AJR Am J Roentgenol. 2017;209:19\u201332.","journal-title":"AJR Am J Roentgenol"},{"key":"1732_CR51","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1016\/j.tem.2020.04.004","volume":"31","author":"V Hasenmajer","year":"2020","unstructured":"Hasenmajer V, Sbardella E, Sciarra F, Minnetti M, Isidori AM, Venneri MA. The immune system in cushing\u2019s syndrome. Trends Endocrinol Metab. 2020;31:655\u201369.","journal-title":"Trends Endocrinol Metab"},{"key":"1732_CR52","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1097\/RLU.0000000000002766","volume":"44","author":"C Diwaker","year":"2019","unstructured":"Diwaker C, Shah RK, Patil V, Jadhav S, Lila A, Bandgar T, et al. 68Ga-DOTATATE PET\/CT of ectopic cushing syndrome due to appendicular carcinoid. Clin Nucl Med. 2019;44:881\u20132.","journal-title":"Clin Nucl Med"},{"key":"1732_CR53","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1111\/cen.14008","volume":"91","author":"T Wannachalee","year":"2019","unstructured":"Wannachalee T, Turcu AF, Bancos I, Habra MA, Avram AM, Chuang HH, et al. The clinical impact of [(68) Ga]-DOTATATE PET\/CT for the diagnosis and management of ectopic adrenocorticotropic hormone\u2014secreting tumours. Clin Endocrinol (Oxf). 2019;91:288\u201394.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1732_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07435800.2024.2381720","volume":"49","author":"M Valizadeh","year":"2024","unstructured":"Valizadeh M, Rahmani F, Nikoohemmat M, Ramezani Ahmadi A, Hosseinpanah F, Niroomand M, et al. Diagnostic accuracy of the desmopressin stimulation test in the comprehensive assessment of ACTH-dependent cushing\u2019s syndrome: a comparative analysis with BIPSS and TSS. Endocr Res. 2024;49:1\u201311.","journal-title":"Endocr Res"},{"key":"1732_CR55","doi-asserted-by":"publisher","first-page":"R29","DOI":"10.1530\/EJE-19-0877","volume":"182","author":"J Young","year":"2020","unstructured":"Young J, Haissaguerre M, Viera-Pinto O, Chabre O, Baudin E, Tabarin A. MANAGEMENT OF ENDOCRINE DISEASE: Cushing\u2019s syndrome due to ectopic ACTH secretion: an expert operational opinion. Eur J Endocrinol. 2020;182:R29-r58.","journal-title":"Eur J Endocrinol"},{"key":"1732_CR56","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1507\/endocrj.EJ18-0025","volume":"65","author":"M Inoue","year":"2018","unstructured":"Inoue M, Okamura K, Kitaoka C, Kinoshita F, Namitome R, Nakamura U, et al. Metyrapone-responsive ectopic ACTH-secreting pheochromocytoma with a vicious cycle via a glucocorticoid-driven positive-feedback mechanism. Endocr J. 2018;65:755\u201367.","journal-title":"Endocr J"},{"key":"1732_CR57","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s12022-022-09710-8","volume":"33","author":"O Mete","year":"2022","unstructured":"Mete O, Erickson LA, Juhlin CC, de Krijger RR, Sasano H, Volante M, et al. Overview of the 2022 WHO classification of adrenal cortical tumors. Endocr Pathol. 2022;33:155\u201396.","journal-title":"Endocr Pathol"},{"key":"1732_CR58","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1148\/radiographics.21.4.g01jl21995","volume":"21","author":"WW Mayo-Smith","year":"2001","unstructured":"Mayo-Smith WW, Boland GW, Noto RB, Lee MJ. State-of-the-art adrenal imaging. Radiographics. 2001;21:995\u20131012.","journal-title":"Radiographics"},{"key":"1732_CR59","doi-asserted-by":"publisher","first-page":"W179","DOI":"10.2214\/AJR.09.2891","volume":"194","author":"FH Miller","year":"2010","unstructured":"Miller FH, Wang Y, McCarthy RJ, Yaghmai V, Merrick L, Larson A, et al. Utility of diffusion-weighted MRI in characterization of adrenal lesions. AJR Am J Roentgenol. 2010;194:W179\u201385.","journal-title":"AJR Am J Roentgenol"},{"key":"1732_CR60","doi-asserted-by":"publisher","first-page":"2807","DOI":"10.1210\/jc.2015-1818","volume":"100","author":"LK Nieman","year":"2015","unstructured":"Nieman LK, Biller BM, Findling JW, Murad MH, Newell-Price J, Savage MO, et al. Treatment of Cushing\u2019s syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2015;100:2807\u201331.","journal-title":"J Clin Endocrinol Metab"},{"key":"1732_CR61","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1093\/ejendo\/lvad066","volume":"189","author":"M Fassnacht","year":"2023","unstructured":"Fassnacht M, Tsagarakis S, Terzolo M, Tabarin A, Sahdev A, Newell-Price J, et al. European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors. Eur J Endocrinol. 2023;189:G1-g42.","journal-title":"Eur J Endocrinol"},{"issue":"Suppl 1","key":"1732_CR62","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1159\/000173949","volume":"72","author":"F Bui","year":"1985","unstructured":"Bui F, Macri C, Varotto L, Boscaro M, Mantero F. Adrenal scintigraphy in the morphological and functional evaluation of Cushing\u2019s syndrome. Cardiology. 1985;72(Suppl 1):76\u201383.","journal-title":"Cardiology"},{"key":"1732_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00268-014-2482-6","volume":"38","author":"MP Ricciato","year":"2014","unstructured":"Ricciato MP, Di Donna V, Perotti G, Pontecorvi A, Bellantone R, Corsello SM. The role of adrenal scintigraphy in the diagnosis of subclinical cushing\u2019s syndrome and the prediction of post-surgical hypoadrenalism. World J Surg. 2014;38:1.","journal-title":"World J Surg"},{"key":"1732_CR64","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1530\/EJE-08-0299","volume":"160","author":"C Fagour","year":"2009","unstructured":"Fagour C, Bardet S, Rohmer V, Arimone Y, Lecomte P, Valli N, et al. Usefulness of adrenal scintigraphy in the follow-up of adrenocortical incidentalomas: a prospective multicenter study. Eur J Endocrinol. 2009;160:257\u201364.","journal-title":"Eur J Endocrinol"},{"key":"1732_CR65","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1097\/MNM.0000000000001391","volume":"42","author":"Y Okada","year":"2021","unstructured":"Okada Y, Matsushita S, Yamaguchi K. Investigation of Cushing\u2019s and subclinical Cushing\u2019s syndromes using adrenocortical scintigraphy. Nucl Med Commun. 2021;42:619\u201324.","journal-title":"Nucl Med Commun"},{"key":"1732_CR66","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1097\/HJH.0000000000002510","volume":"38","author":"P Mulatero","year":"2020","unstructured":"Mulatero P, Monticone S, Deinum J, Amar L, Prejbisz A, Zennaro MC, et al. Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the working group on endocrine hypertension of the european society of hypertension. J Hypertens. 2020;38:1919\u201328.","journal-title":"J Hypertens"},{"key":"1732_CR67","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1210\/jc.2015-4061","volume":"101","author":"JW Funder","year":"2016","unstructured":"Funder JW, Carey RM, Mantero F, Murad MH, Reincke M, Shibata H, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2016;101:1889\u2013916.","journal-title":"J Clin Endocrinol Metab"},{"key":"1732_CR68","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.2967\/jnumed.109.064873","volume":"50","author":"RF Yen","year":"2009","unstructured":"Yen RF, Wu VC, Liu KL, Cheng MF, Wu YW, Chueh SC, et al. 131I\u20136beta-iodomethyl-19-norcholesterol SPECT\/CT for primary aldosteronism patients with inconclusive adrenal venous sampling and CT results. J Nucl Med. 2009;50:1631\u20137.","journal-title":"J Nucl Med"},{"key":"1732_CR69","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1177\/145749690809700308","volume":"97","author":"C Volpe","year":"2008","unstructured":"Volpe C, Enberg U, Sj\u00f6gren A, Wahrenberg H, Jacobsson H, T\u00f6rring O, et al. The role of adrenal scintigraphy in the preoperative management of primary aldosteronism. Scand J Surg. 2008;97:248\u201353.","journal-title":"Scand J Surg"},{"key":"1732_CR70","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.jamcollsurg.2005.11.005","volume":"202","author":"C Sturgeon","year":"2006","unstructured":"Sturgeon C, Shen WT, Clark OH, Duh Q-Y, Kebebew E. Risk assessment in 457 adrenal cortical carcinomas: how much does tumor size predict the likelihood of malignancy? J Am Coll Surg. 2006;202:423\u201330.","journal-title":"J Am Coll Surg"},{"key":"1732_CR71","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.4158\/DSCR-2020-0567","volume":"26","author":"K Kiseljak-Vassiliades","year":"2020","unstructured":"Kiseljak-Vassiliades K, Bancos I, Hamrahian A, Habra M, Vaidya A, Levine AC, et al. American association of clinical endocrinology disease state clinical review on the evaluation and management of adrenocortical carcinoma in an adult: a practical approach. Endocr Pract. 2020;26:1366\u201383.","journal-title":"Endocr Pract"},{"key":"1732_CR72","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.path.2019.08.005","volume":"12","author":"A Hodgson","year":"2019","unstructured":"Hodgson A, Pakbaz S, Mete O. A diagnostic approach to adrenocortical tumors. Surg Pathol Clin. 2019;12:967\u201395.","journal-title":"Surg Pathol Clin"},{"key":"1732_CR73","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/0720-048X(94)00587-3","volume":"19","author":"R Soler","year":"1995","unstructured":"Soler R, Rodr\u00edguez E, L\u00f3pez MF, Marini M. MR imaging in inferior vena cava thrombosis. Eur J Radiol. 1995;19:101\u20137.","journal-title":"Eur J Radiol"},{"key":"1732_CR74","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.3390\/cancers13071603","volume":"13","author":"A Kedra","year":"2021","unstructured":"Kedra A, Dohan A, Gaujoux S, Sibony M, Jouinot A, Assi\u00e9 G, et al. Preoperative detection of liver involvement by right-sided adrenocortical carcinoma using CT and MRI. Cancers (Basel). 2021;13:1603.","journal-title":"Cancers (Basel)"},{"key":"1732_CR75","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1007\/s12672-011-0089-z","volume":"2","author":"WF Young Jr","year":"2011","unstructured":"Young WF Jr. Conventional imaging in adrenocortical carcinoma: update and perspectives. Horm Cancer. 2011;2:341\u20137.","journal-title":"Horm Cancer"},{"key":"1732_CR76","doi-asserted-by":"publisher","first-page":"W706","DOI":"10.2214\/AJR.10.5540","volume":"196","author":"N Bharwani","year":"2011","unstructured":"Bharwani N, Rockall AG, Sahdev A, Gueorguiev M, Drake W, Grossman AB, et al. Adrenocortical carcinoma: the range of appearances on CT and MRI. AJR Am J Roentgenol. 2011;196:W706\u201314.","journal-title":"AJR Am J Roentgenol"},{"key":"1732_CR77","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1210\/clinem\/dgad138","volume":"108","author":"M Schaafsma","year":"2023","unstructured":"Schaafsma M, Berends AMA, Links TP, Brouwers AH, Kerstens MN. The diagnostic value of 18F-FDG PET\/CT scan in characterizing adrenal tumors. J Clin Endocrinol Metab. 2023;108:2435\u201345.","journal-title":"J Clin Endocrinol Metab"},{"key":"1732_CR78","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1677\/erc.1.01130","volume":"14","author":"R Lib\u00e8","year":"2007","unstructured":"Lib\u00e8 R, Fratticci A, Bertherat J. Adrenocortical cancer: pathophysiology and clinical management. Endocr Relat Cancer. 2007;14:13\u201328.","journal-title":"Endocr Relat Cancer"},{"key":"1732_CR79","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1111\/cas.15379","volume":"113","author":"T Kamai","year":"2022","unstructured":"Kamai T, Murakami S, Arai K, Ishida K, Kijima T. Association of Nrf2 expression and mutation with Weiss and Helsinki scores in adrenocortical carcinoma. Cancer Sci. 2022;113:2368\u201377.","journal-title":"Cancer Sci"},{"key":"1732_CR80","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.humpath.2014.11.015","volume":"46","author":"M Pennanen","year":"2015","unstructured":"Pennanen M, Heiskanen I, Sane T, Remes S, Mustonen H, Haglund C, et al. Helsinki score-a novel model for prediction of metastases in adrenocortical carcinomas. Hum Pathol. 2015;46:404\u201310.","journal-title":"Hum Pathol"},{"key":"1732_CR81","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.1007\/s00268-011-1374-2","volume":"36","author":"L Gust","year":"2012","unstructured":"Gust L, Taieb D, Beliard A, Barlier A, Morange I, de Micco C, et al. Preoperative 18F-FDG uptake is strongly correlated with malignancy, Weiss score, and molecular markers of aggressiveness in adrenal cortical tumors. World J Surg. 2012;36:1406\u201310.","journal-title":"World J Surg"},{"key":"1732_CR82","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1210\/clinem\/dgac046","volume":"107","author":"M Daher","year":"2022","unstructured":"Daher M, Varghese J, Gruschkus SK, Jimenez C, Waguespack SG, Bedrose S, et al. Temporal trends in outcomes in patients with adrenocortical carcinoma: a multidisciplinary referral-center experience. J Clin Endocrinol Metab. 2022;107:1239\u201346.","journal-title":"J Clin Endocrinol Metab"},{"key":"1732_CR83","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s00261-019-02371-y","volume":"45","author":"AA Ahmed","year":"2020","unstructured":"Ahmed AA, Thomas AJ, Ganeshan DM, Blair KJ, Lall C, Lee JT, et al. Adrenal cortical carcinoma: pathology, genomics, prognosis, imaging features, and mimics with impact on management. Abdom Radiol (NY). 2020;45:945\u201363.","journal-title":"Abdom Radiol (NY)"},{"key":"1732_CR84","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1056\/NEJMra1806651","volume":"381","author":"HPH Neumann","year":"2019","unstructured":"Neumann HPH, Young WF Jr, Eng C. Pheochromocytoma and paraganglioma. N Engl J Med. 2019;381:552\u201365.","journal-title":"N Engl J Med"},{"key":"1732_CR85","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.1007\/s00261-017-1198-0","volume":"42","author":"E Fonseca","year":"2017","unstructured":"Fonseca E, Ponte M, Yamauchi FI, Baroni RH. The light bulb sign in pheochromocytoma. Abdom Radiol (NY). 2017;42:2779.","journal-title":"Abdom Radiol (NY)"},{"key":"1732_CR86","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00330-004-2412-3","volume":"15","author":"A Sahdev","year":"2005","unstructured":"Sahdev A, Sohaib A, Monson JP, Grossman AB, Chew SL, Reznek RH. CT and MR imaging of unusual locations of extra-adrenal paragangliomas (pheochromocytomas). Eur Radiol. 2005;15:85\u201392.","journal-title":"Eur Radiol"},{"key":"1732_CR87","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1007\/s00261-024-04289-6","volume":"49","author":"A Djuric-Stefanovic","year":"2024","unstructured":"Djuric-Stefanovic A, Toncev J, Mijovic K. \u201cSalt-and-pepper\u201d sign. Abdom Radiol (NY). 2024;49:2552\u20133.","journal-title":"Abdom Radiol (NY)"},{"key":"1732_CR88","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1097\/RCT.0b013e3181d529f2","volume":"34","author":"KM Elsayes","year":"2010","unstructured":"Elsayes KM, Menias CO, Siegel CL, Narra VR, Kanaan Y, Hussain HK. Magnetic resonance characterization of pheochromocytomas in the abdomen and pelvis: imaging findings in 18 surgically proven cases. J Comput Assist Tomogr. 2010;34:548\u201353.","journal-title":"J Comput Assist Tomogr"},{"key":"1732_CR89","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.3174\/ajnr.A7166","volume":"42","author":"Y Ota","year":"2021","unstructured":"Ota Y, Naganawa S, Kurokawa R, Bapuraj JR, Capizzano A, Kim J, et al. Assessment of MR imaging and CT in differentiating hereditary and nonhereditary paragangliomas. AJNR Am J Neuroradiol. 2021;42:1320\u20136.","journal-title":"AJNR Am J Neuroradiol"},{"key":"1732_CR90","first-page":"1839","volume":"42","author":"Y Ota","year":"2021","unstructured":"Ota Y, Liao E, Capizzano AA, Kurokawa R, Bapuraj JR, Syed F, et al. Diagnostic role of diffusion-weighted and dynamic contrast-enhanced perfusion MR imaging in paragangliomas and schwannomas in the head and neck. AJNR Am J Neuroradiol. 2021;42:1839\u201346.","journal-title":"AJNR Am J Neuroradiol"},{"key":"1732_CR91","first-page":"122","volume":"57","author":"V Rufini","year":"2013","unstructured":"Rufini V, Treglia G, Castaldi P, Perotti G, Giordano A. Comparison of metaiodobenzylguanidine scintigraphy with positron emission tomography in the diagnostic work-up of pheochromocytoma and paraganglioma: a systematic review. Q J Nucl Med Mol Imaging. 2013;57:122\u201333.","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"1732_CR92","doi-asserted-by":"publisher","first-page":"2596","DOI":"10.1210\/jc.2009-2604","volume":"95","author":"AF Jacobson","year":"2010","unstructured":"Jacobson AF, Deng H, Lombard J, Lessig HJ, Black RR. 123I-meta-iodobenzylguanidine scintigraphy for the detection of neuroblastoma and pheochromocytoma: results of a meta-analysis. J Clin Endocrinol Metab. 2010;95:2596\u2013606.","journal-title":"J Clin Endocrinol Metab"},{"key":"1732_CR93","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40644-016-0084-2","volume":"16","author":"CA Chang","year":"2016","unstructured":"Chang CA, Pattison DA, Tothill RW, Kong G, Akhurst TJ, Hicks RJ, et al. (68)Ga-DOTATATE and (18)F-FDG PET\/CT in paraganglioma and pheochromocytoma: utility, patterns and heterogeneity. Cancer Imaging. 2016;16:22.","journal-title":"Cancer Imaging"},{"key":"1732_CR94","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1530\/ERC-11-0243","volume":"19","author":"JS Fonte","year":"2012","unstructured":"Fonte JS, Robles JF, Chen CC, Reynolds J, Whatley M, Ling A, et al. False-negative 123I-MIBG SPECT is most commonly found in SDHB-related pheochromocytoma or paraganglioma with high frequency to develop metastatic disease. Endocr Relat Cancer. 2012;19:83\u201393.","journal-title":"Endocr Relat Cancer"},{"key":"1732_CR95","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1007\/s00259-019-04398-1","volume":"46","author":"D Ta\u00efeb","year":"2019","unstructured":"Ta\u00efeb D, Hicks RJ, Hindi\u00e9 E, Guillet BA, Avram A, Ghedini P, et al. European association of nuclear medicine practice guideline\/society of nuclear medicine and molecular imaging procedure standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma. Eur J Nucl Med Mol Imaging. 2019;46:2112\u201337.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1732_CR96","doi-asserted-by":"publisher","first-page":"3812","DOI":"10.1210\/jc.2018-02355","volume":"104","author":"D Rao","year":"2019","unstructured":"Rao D, van Berkel A, Piscaer I, Young WF, Gruber L, Deutschbein T, et al. Impact of 123I-MIBG scintigraphy on clinical decision-making in pheochromocytoma and paraganglioma. J Clin Endocrinol Metab. 2019;104:3812\u201320.","journal-title":"J Clin Endocrinol Metab"},{"key":"1732_CR97","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.2967\/jnumed.120.259697","volume":"62","author":"JA Carrasquillo","year":"2021","unstructured":"Carrasquillo JA, Chen CC, Jha A, Pacak K, Pryma DA, Lin FI. Systemic radiopharmaceutical therapy of pheochromocytoma and paraganglioma. J Nucl Med. 2021;62:1192\u20139.","journal-title":"J Nucl Med"},{"key":"1732_CR98","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1007\/s13139-018-0523-z","volume":"52","author":"D Kayano","year":"2018","unstructured":"Kayano D, Kinuya S. Current consensus on I-131 MIBG therapy. Nucl Med Mol Imaging. 2018;52:254\u201365.","journal-title":"Nucl Med Mol Imaging"},{"key":"1732_CR99","doi-asserted-by":"publisher","first-page":"623","DOI":"10.2967\/jnumed.118.217463","volume":"60","author":"DA Pryma","year":"2019","unstructured":"Pryma DA, Chin BB, Noto RB, Dillon JS, Perkins S, Solnes L, et al. Efficacy and safety of high-specific-activity (131)I-MIBG therapy in patients with advanced pheochromocytoma or paraganglioma. J Nucl Med. 2019;60:623\u201330.","journal-title":"J Nucl Med"},{"key":"1732_CR100","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/cen.12341","volume":"80","author":"LT van Hulsteijn","year":"2014","unstructured":"van Hulsteijn LT, Niemeijer ND, Dekkers OM, Corssmit EP. (131)I-MIBG therapy for malignant paraganglioma and phaeochromocytoma: systematic review and meta-analysis. Clin Endocrinol (Oxf). 2014;80:487\u2013501.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1732_CR101","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1146\/annurev-med-011514-023121","volume":"66","author":"CU Louis","year":"2015","unstructured":"Louis CU, Shohet JM. Neuroblastoma: molecular pathogenesis and therapy. Annu Rev Med. 2015;66:49\u201363.","journal-title":"Annu Rev Med"},{"key":"1732_CR102","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1148\/radiol.11101352","volume":"261","author":"HJ Brisse","year":"2011","unstructured":"Brisse HJ, McCarville MB, Granata C, Krug KB, Wootton-Gorges SL, Kanegawa K, et al. Guidelines for imaging and staging of neuroblastic tumors: consensus report from the International Neuroblastoma Risk Group Project. Radiology. 2011;261:243\u201357.","journal-title":"Radiology"},{"key":"1732_CR103","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1148\/radiographics.22.4.g02jl15911","volume":"22","author":"GJ Lonergan","year":"2002","unstructured":"Lonergan GJ, Schwab CM, Suarez ES, Carlson CL. Neuroblastoma, ganglioneuroblastoma, and ganglioneuroma: radiologic-pathologic correlation. Radiographics. 2002;22:911\u201334.","journal-title":"Radiographics"},{"key":"1732_CR104","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s40644-015-0040-6","volume":"15","author":"M Dumba","year":"2015","unstructured":"Dumba M, Jawad N, McHugh K. Neuroblastoma and nephroblastoma: a radiological review. Cancer Imaging. 2015;15:5.","journal-title":"Cancer Imaging"},{"key":"1732_CR105","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.ejrad.2010.05.041","volume":"75","author":"Y Xu","year":"2010","unstructured":"Xu Y, Wang J, Peng Y, Zeng J. CT characteristics of primary retroperitoneal neoplasms in children. Eur J Radiol. 2010;75:321\u20138.","journal-title":"Eur J Radiol"},{"key":"1732_CR106","doi-asserted-by":"publisher","first-page":"129","DOI":"10.4103\/0971-3026.155844","volume":"25","author":"SA Kembhavi","year":"2015","unstructured":"Kembhavi SA, Shah S, Rangarajan V, Qureshi S, Popat P, Kurkure P. Imaging in neuroblastoma: an update. Indian J Radiol Imaging. 2015;25:129\u201336.","journal-title":"Indian J Radiol Imaging"},{"key":"1732_CR107","doi-asserted-by":"publisher","first-page":"403","DOI":"10.5152\/dir.2017.16541","volume":"23","author":"M Aslan","year":"2017","unstructured":"Aslan M, Aslan A, Ar\u0131\u00f6z Habibi H, Kalyoncu U\u00e7ar A, \u00d6zmen E, Bakan S, et al. Diffusion-weighted MRI for differentiating Wilms tumor from neuroblastoma. Diagn Interv Radiol. 2017;23:403\u20136.","journal-title":"Diagn Interv Radiol"},{"key":"1732_CR108","first-page":"Cd009263","volume":"2015","author":"G Bleeker","year":"2015","unstructured":"Bleeker G, Tytgat GA, Adam JA, Caron HN, Kremer LC, Hooft L, et al. 123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma. Cochrane Database Syst Rev. 2015;2015:Cd009263.","journal-title":"Cochrane Database Syst Rev"},{"key":"1732_CR109","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12957-023-03011-y","volume":"21","author":"S Liu","year":"2023","unstructured":"Liu S, Yin W, Lin Y, Huang S, Xue S, Sun G, et al. Metastasis pattern and prognosis in children with neuroblastoma. World J Surg Oncol. 2023;21:130.","journal-title":"World J Surg Oncol"},{"key":"1732_CR110","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1007\/s00247-019-04397-2","volume":"49","author":"KE Orr","year":"2019","unstructured":"Orr KE, McHugh K. The new international neuroblastoma response criteria. Pediatr Radiol. 2019;49:1433\u201340.","journal-title":"Pediatr Radiol"},{"key":"1732_CR111","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1200\/JCO.2008.16.6876","volume":"27","author":"T Monclair","year":"2009","unstructured":"Monclair T, Brodeur GM, Ambros PF, Brisse HJ, Cecchetto G, Holmes K, et al. The international neuroblastoma risk group (INRG) staging system: an INRG task force report. J Clin Oncol. 2009;27:298\u2013303.","journal-title":"J Clin Oncol"},{"key":"1732_CR112","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.1200\/JCO.21.00278","volume":"39","author":"MS Irwin","year":"2021","unstructured":"Irwin MS, Naranjo A, Zhang FF, Cohn SL, London WB, Gastier-Foster JM, et al. Revised neuroblastoma risk classification system: a report from the children\u2019s oncology group. J Clin Oncol. 2021;39:3229\u201341.","journal-title":"J Clin Oncol"},{"key":"1732_CR113","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1002\/1097-0142(20010515)91:10<1905::AID-CNCR1213>3.0.CO;2-4","volume":"91","author":"B Geoerger","year":"2001","unstructured":"Geoerger B, Hero B, Harms D, Grebe J, Scheidhauer K, Berthold F. Metabolic activity and clinical features of primary ganglioneuromas. Cancer. 2001;91:1905\u201313.","journal-title":"Cancer"},{"issue":"Suppl 1","key":"1732_CR114","doi-asserted-by":"publisher","first-page":"S103","DOI":"10.1016\/j.ijsu.2017.03.086","volume":"41","author":"M Iacobone","year":"2017","unstructured":"Iacobone M, Torresan F, Citton M, Schiavone D, Viel G, Favia G. Adrenal ganglioneuroma: the padua endocrine surgery unit experience. Int J Surg. 2017;41(Suppl 1):S103\u20138.","journal-title":"Int J Surg"},{"key":"1732_CR115","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26964","volume":"65","author":"N Alexander","year":"2018","unstructured":"Alexander N, Sullivan K, Shaikh F, Irwin MS. Characteristics and management of ganglioneuroma and ganglioneuroblastoma-intermixed in children and adolescents. Pediatr Blood Cancer. 2018;65: e26964.","journal-title":"Pediatr Blood Cancer"},{"key":"1732_CR116","doi-asserted-by":"publisher","first-page":"4301","DOI":"10.1007\/s00381-024-06603-5","volume":"40","author":"F Bteich","year":"2024","unstructured":"Bteich F, Larmure O, Stella I, Klein O, Joud A. Spinal ganglioneuroma: a rare and challenging tumor in the pediatric population. Childs Nerv Syst. 2024;40:4301\u20137.","journal-title":"Childs Nerv Syst"},{"key":"1732_CR117","doi-asserted-by":"publisher","first-page":"5263","DOI":"10.12659\/MSM.916792","volume":"25","author":"L Luo","year":"2019","unstructured":"Luo L, Zheng X, Tao KZ, Zhang J, Tang YY, Han FG. Imaging analysis of ganglioneuroma and quantitative analysis of paraspinal ganglioneuroma. Med Sci Monit. 2019;25:5263\u201371.","journal-title":"Med Sci Monit"},{"key":"1732_CR118","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1259\/0007-1285-69-818-114","volume":"69","author":"T Ichikawa","year":"1996","unstructured":"Ichikawa T, Ohtomo K, Araki T, Fujimoto H, Nemoto K, Nanbu A, et al. Ganglioneuroma: computed tomography and magnetic resonance features. Br J Radiol. 1996;69:114\u201321.","journal-title":"Br J Radiol"},{"key":"1732_CR119","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1097\/00004728-200107000-00018","volume":"25","author":"Y Zhang","year":"2001","unstructured":"Zhang Y, Nishimura H, Kato S, Fujimoto K, Ohkuma K, Kojima K, et al. MRI of ganglioneuroma: histologic correlation study. J Comput Assist Tomogr. 2001;25:617\u201323.","journal-title":"J Comput Assist Tomogr"},{"key":"1732_CR120","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1007\/s00259-013-2491-y","volume":"40","author":"WP Fendler","year":"2013","unstructured":"Fendler WP, Melzer HI, Walz C, von Schweinitz D, Coppenrath E, Schmid I, et al. High 123I-MIBG uptake in neuroblastic tumors indicates unfavourable histopathology. Eur J Nucl Med Mol Imaging. 2013;40:1701\u201310.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1732_CR121","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1007\/s00259-011-1843-8","volume":"38","author":"HI Melzer","year":"2011","unstructured":"Melzer HI, Coppenrath E, Schmid I, Albert MH, von Schweinitz D, Tudball C, et al. 123I-MIBG scintigraphy\/SPECT versus 1\u2078F-FDG PET in paediatric neuroblastoma. Eur J Nucl Med Mol Imaging. 2011;38:1648\u201358.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1732_CR122","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1210\/clinem\/dgab512","volume":"106","author":"I Bancos","year":"2021","unstructured":"Bancos I, Prete A. Approach to the patient with adrenal incidentaloma. J Clin Endocrinol Metab. 2021;106:3331\u201353.","journal-title":"J Clin Endocrinol Metab"},{"key":"1732_CR123","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.2214\/AJR.07.2167","volume":"189","author":"JH Song","year":"2007","unstructured":"Song JH, Chaudhry FS, Mayo-Smith WW. The incidental indeterminate adrenal mass on CT (> 10 H) in patients without cancer: is further imaging necessary? Follow-up of 321 consecutive indeterminate adrenal masses. AJR Am J Roentgenol. 2007;189:1119\u201323.","journal-title":"AJR Am J Roentgenol"},{"key":"1732_CR124","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1148\/radiology.208.1.9646797","volume":"208","author":"PJ Kenney","year":"1998","unstructured":"Kenney PJ, Wagner BJ, Rao P, Heffess CS. Myelolipoma: CT and pathologic features. Radiology. 1998;208:87\u201395.","journal-title":"Radiology"},{"key":"1732_CR125","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1097\/00000478-198206000-00009","volume":"6","author":"MR Fowler","year":"1982","unstructured":"Fowler MR, Williams RB, Alba JM, Byrd CR. Extra-adrenal myelolipomas compared with extramedullary hematopoietic tumors: a case of presacral myelolipoma. Am J Surg Pathol. 1982;6:363\u201374.","journal-title":"Am J Surg Pathol"},{"key":"1732_CR126","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s12020-017-1473-4","volume":"59","author":"\u00c1 Decmann","year":"2018","unstructured":"Decmann \u00c1, Perge P, T\u00f3th M, Igaz P. Adrenal myelolipoma: a comprehensive review. Endocrine. 2018;59:7\u201315.","journal-title":"Endocrine"},{"key":"1732_CR127","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.2214\/AJR.16.17758","volume":"208","author":"N Schieda","year":"2017","unstructured":"Schieda N, Siegelman ES. Update on CT and MRI of adrenal nodules. AJR Am J Roentgenol. 2017;208:1206\u201317.","journal-title":"AJR Am J Roentgenol"},{"key":"1732_CR128","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.crad.2014.06.020","volume":"69","author":"N Schieda","year":"2014","unstructured":"Schieda N, Al Dandan O, Kielar AZ, Flood TA, McInnes MD, Siegelman ES. Pitfalls of adrenal imaging with chemical shift MRI. Clin Radiol. 2014;69:1186\u201397.","journal-title":"Clin Radiol"},{"key":"1732_CR129","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/cen.14188","volume":"93","author":"O Hamidi","year":"2020","unstructured":"Hamidi O, Raman R, Lazik N, Iniguez-Ariza N, McKenzie TJ, Lyden ML, et al. Clinical course of adrenal myelolipoma: a long-term longitudinal follow-up study. Clin Endocrinol (Oxf). 2020;93:11\u20138.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1732_CR130","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1148\/radiographics.17.6.9397452","volume":"17","author":"P Rao","year":"1997","unstructured":"Rao P, Kenney PJ, Wagner BJ, Davidson AJ. Imaging and pathologic features of myelolipoma. Radiographics. 1997;17:1373\u201385.","journal-title":"Radiographics"},{"key":"1732_CR131","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2022.100438","volume":"35","author":"J Cao","year":"2022","unstructured":"Cao J, Huang X, Cui N, Wang X, You C, Ni X, et al. Surgical management and outcome of Extra-adrenal myelolipomas at unusual locations: a report of 11 cases in a single center. J Bone Oncol. 2022;35: 100438.","journal-title":"J Bone Oncol"},{"key":"1732_CR132","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.ejrad.2017.05.039","volume":"93","author":"LA Littrell","year":"2017","unstructured":"Littrell LA, Carter JM, Broski SM, Wenger DE. Extra-adrenal myelolipoma and extramedullary hematopoiesis: imaging features of two similar benign fat-containing presacral masses that may mimic liposarcoma. Eur J Radiol. 2017;93:185\u201394.","journal-title":"Eur J Radiol"},{"key":"1732_CR133","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1148\/rg.291085203","volume":"29","author":"WD Craig","year":"2009","unstructured":"Craig WD, Fanburg-Smith JC, Henry LR, Guerrero R, Barton JH. Fat-containing lesions of the retroperitoneum: radiologic-pathologic correlation. Radiographics. 2009;29:261\u201390.","journal-title":"Radiographics"},{"key":"1732_CR134","doi-asserted-by":"publisher","first-page":"470","DOI":"10.2214\/AJR.15.15280","volume":"207","author":"JJ Lee","year":"2016","unstructured":"Lee JJ, Dickson BC, Sreeharsha B, Gladdy RA, Thipphavong S. Presacral myelolipoma: diagnosis on imaging with pathologic and clinical correlation. AJR Am J Roentgenol. 2016;207:470\u201381.","journal-title":"AJR Am J Roentgenol"},{"key":"1732_CR135","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1038\/modpathol.2009.87","volume":"22","author":"A Mozos","year":"2009","unstructured":"Mozos A, Ye H, Chuang WY, Chu JS, Huang WT, Chen HK, et al. Most primary adrenal lymphomas are diffuse large B-cell lymphomas with non-germinal center B-cell phenotype, BCL6 gene rearrangement and poor prognosis. Mod Pathol. 2009;22:1210\u20137.","journal-title":"Mod Pathol"},{"key":"1732_CR136","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3389\/fendo.2020.00595","volume":"11","author":"Y Wang","year":"2020","unstructured":"Wang Y, Ren Y, Ma L, Li J, Zhu Y, Zhao L, et al. Clinical features of 50 patients with primary adrenal lymphoma. Front Endocrinol (Lausanne). 2020;11:595.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1732_CR137","unstructured":"Rong-ju S. CT and MR imaging findings of primary adrenal lymphoma. J Med Imaging, 2015."},{"key":"1732_CR138","doi-asserted-by":"publisher","first-page":"8571","DOI":"10.21037\/qims-23-803","volume":"13","author":"W Huang","year":"2023","unstructured":"Huang W, Chao F, Li L, Gao Y, Qiu Y, Wang W, et al. Predictive value of clinical characteristics and baseline (18)F-FDG PET\/CT quantization parameters in primary adrenal diffuse large B-cell lymphoma: a preliminary study. Quant Imaging Med Surg. 2023;13:8571-86. https:\/\/doi.org\/10.21037\/qims-23-803.","journal-title":"Quant Imaging Med Surg"},{"key":"1732_CR139","doi-asserted-by":"publisher","first-page":"6777","DOI":"10.1002\/cam4.4198","volume":"10","author":"A Satou","year":"2021","unstructured":"Satou A, Nakamura S. EBV-positive B-cell lymphomas and lymphoproliferative disorders: review from the perspective of immune escape and immunodeficiency. Cancer Med. 2021;10:6777\u201385.","journal-title":"Cancer Med"},{"key":"1732_CR140","doi-asserted-by":"publisher","first-page":"20160879","DOI":"10.1259\/bjr.20160879","volume":"90","author":"K Tokuyama","year":"2017","unstructured":"Tokuyama K, Okada F, Sato H, Matsumoto S, Matsumoto A, Haruno A, et al. Computed tomography findings in Epstein-Barr virus (EBV)-positive diffuse large B-cell lymphoma (DLBCL) of the elderly: comparison with EBV-negative DLBCL. Br J Radiol. 2017;90:20160879.","journal-title":"Br J Radiol"},{"key":"1732_CR141","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1530\/EJE-19-0506","volume":"183","author":"F Majidi","year":"2020","unstructured":"Majidi F, Martino S, Kondakci M, Antke C, Haase M, Chortis V, et al. Clinical spectrum of primary adrenal lymphoma: results of a multicenter cohort study. Eur J Endocrinol. 2020;183:453\u201362.","journal-title":"Eur J Endocrinol"},{"key":"1732_CR142","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1007\/s00277-013-1812-3","volume":"92","author":"A Rashidi","year":"2013","unstructured":"Rashidi A, Fisher SI. Primary adrenal lymphoma: a systematic review. Ann Hematol. 2013;92:1583\u201393.","journal-title":"Ann Hematol"},{"key":"1732_CR143","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s12020-014-0440-6","volume":"49","author":"A Kandathil","year":"2015","unstructured":"Kandathil A, Wong KK, Wale DJ, Zatelli MC, Maffione AM, Gross MD, et al. Metabolic and anatomic characteristics of benign and malignant adrenal masses on positron emission tomography\/computed tomography: a review of literature. Endocrine. 2015;49:6\u201326.","journal-title":"Endocrine"},{"key":"1732_CR144","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s42000-022-00423-5","volume":"22","author":"J Maciel","year":"2023","unstructured":"Maciel J, Cavaco D, Fraga D, Donato S, Sim\u00f5es H, Sousa R, et al. Adrenal findings in FDG-PET: analysis of a cohort of 1021 patients from a cancer center. Hormones (Athens). 2023;22:131\u20138.","journal-title":"Hormones (Athens)"},{"key":"1732_CR145","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1097\/MNM.0b013e32834199e7","volume":"32","author":"P Ozcan Kara","year":"2011","unstructured":"Ozcan Kara P, Kara T, Kara Gedik G, Kara F, Sahin O, Ceylan Gunay E, et al. The role of fluorodeoxyglucose-positron emission tomography\/computed tomography in differentiating between benign and malignant adrenal lesions. Nucl Med Commun. 2011;32:106\u201312.","journal-title":"Nucl Med Commun"},{"key":"1732_CR146","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s00259-021-05533-7","volume":"49","author":"H Jiang","year":"2022","unstructured":"Jiang H, Li A, Liao S, Ke S, Ji Z, Tian M, et al. Simultaneous adrenal tuberculosis and renal oncocytoma mimicking malignant masses incidentally detected by (18)F-FDG PET\/CT in a patient with lymphoma. Eur J Nucl Med Mol Imaging. 2022;49:777\u20138.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1732_CR147","doi-asserted-by":"publisher","first-page":"3431","DOI":"10.21037\/gs-21-511","volume":"10","author":"Q Teng","year":"2021","unstructured":"Teng Q, Fan B, Wang Y, Wen S, Wang H, Liu T, et al. Primary adrenal tuberculosis infection in patients with Behcet\u2019s disease presenting as isolated adrenal metastasis by (18)F-FDG PET\/CT: a rare case report and literature review. Gland Surg. 2021;10:3431\u201342.","journal-title":"Gland Surg"},{"key":"1732_CR148","doi-asserted-by":"publisher","first-page":"20210753","DOI":"10.1259\/bjr.20210753","volume":"94","author":"M Badawy","year":"2021","unstructured":"Badawy M, Gaballah AH, Ganeshan D, Abdelalziz A, Remer EM, Alsabbagh M, et al. Adrenal hemorrhage and hemorrhagic masses; diagnostic workup and imaging findings. Br J Radiol. 2021;94:20210753.","journal-title":"Br J Radiol"},{"key":"1732_CR149","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1056\/NEJMoa044194","volume":"353","author":"PV Adem","year":"2005","unstructured":"Adem PV, Montgomery CP, Husain AN, Koogler TK, Arangelovich V, Humilier M, et al. Staphylococcus aureus sepsis and the Waterhouse-Friderichsen syndrome in children. N Engl J Med. 2005;353:1245\u201351.","journal-title":"N Engl J Med"},{"key":"1732_CR150","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2214\/AJR.13.11793","volume":"203","author":"A Dong","year":"2014","unstructured":"Dong A, Cui Y, Wang Y, Zuo C, Bai Y. (18)F-FDG PET\/CT of adrenal lesions. AJR Am J Roentgenol. 2014;203:245\u201352.","journal-title":"AJR Am J Roentgenol"},{"key":"1732_CR151","doi-asserted-by":"publisher","first-page":"5588","DOI":"10.1007\/s00330-020-06919-1","volume":"30","author":"R Kurokawa","year":"2020","unstructured":"Kurokawa R, Gonoi W, Yokota H, Isshiki S, Ohira K, Mizuno H, et al. Computed tomography findings of early-stage TAFRO syndrome and associated adrenal abnormalities. Eur Radiol. 2020;30:5588\u201398.","journal-title":"Eur Radiol"},{"key":"1732_CR152","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s00330-020-07226-5","volume":"31","author":"P Leyendecker","year":"2021","unstructured":"Leyendecker P, Ritter S, Riou M, Wackenthaler A, Meziani F, Roy C, et al. Acute adrenal infarction as an incidental CT finding and a potential prognosis factor in severe SARS-CoV-2 infection: a retrospective cohort analysis on 219 patients. Eur Radiol. 2021;31:895\u2013900.","journal-title":"Eur Radiol"},{"key":"1732_CR153","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/0899-7071(92)90121-O","volume":"16","author":"TB Buxi","year":"1992","unstructured":"Buxi TB, Vohra RB, Byotra SP, Mukherji S, Daniel M. CT in adrenal enlargement due to tuberculosis: a review of literature with five new cases. Clin Imaging. 1992;16:102\u20138.","journal-title":"Clin Imaging"},{"key":"1732_CR154","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1007\/s00261-007-9352-8","volume":"33","author":"XC Zhang","year":"2008","unstructured":"Zhang XC, Yang ZG, Li Y, Min PQ, Guo YK, Deng YP, et al. Addison\u2019s disease due to adrenal tuberculosis: MRI features. Abdom Imaging. 2008;33:689\u201394.","journal-title":"Abdom Imaging"},{"key":"1732_CR155","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1080\/028418500127345929","volume":"41","author":"H Parmar","year":"2000","unstructured":"Parmar H, Shah J, Patkar D, Varma R. Intramedullary tuberculomas. MR findings in seven patients. Acta Radiol. 2000;41:572\u20137.","journal-title":"Acta Radiol"},{"key":"1732_CR156","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1097\/00002030-199714000-00008","volume":"11","author":"Y Hoshino","year":"1997","unstructured":"Hoshino Y, Nagata Y, Gatanaga H, Hosono O, Morimoto C, Tachikawa N, et al. Cytomegalovirus (CMV) retinitis and CMV antigenemia as a clue to impaired adrenocortical function in patients with AIDS. AIDS. 1997;11:1719\u201324.","journal-title":"AIDS"},{"key":"1732_CR157","doi-asserted-by":"publisher","first-page":"rjac122","DOI":"10.1093\/jscr\/rjac122","volume":"2022","author":"JS Park","year":"2022","unstructured":"Park JS, Ben-David M, McKenzie C, Sandroussi C. Cytomegalovirus adrenalitis mimicking adrenal metastasis in an immunocompetent patient. J Surg Case Rep. 2022;2022:rjac122.","journal-title":"J Surg Case Rep"}],"container-title":["Japanese Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11604-025-01732-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11604-025-01732-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11604-025-01732-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,30]],"date-time":"2025-05-30T06:02:09Z","timestamp":1748584929000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11604-025-01732-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,11]]},"references-count":157,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["1732"],"URL":"https:\/\/doi.org\/10.1007\/s11604-025-01732-6","relation":{},"ISSN":["1867-1071","1867-108X"],"issn-type":[{"value":"1867-1071","type":"print"},{"value":"1867-108X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,11]]},"assertion":[{"value":"16 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests that are relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}